The Food and Drug Administration has launched a safety review of mifepristone, the drug used for medicated abortions, according to the Wall Street Journal.
The review comes as some anti-abortion advocates have grown increasingly frustrated with the Trump administration, arguing it has moved too slowly on promises to revisit federal abortion pill regulations ahead of the midterm elections.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.